Highline Wealth Partners’s Gilead Sciences GILD Stock Holding History

Highline Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.3K	Buy	446 +20	+5%	+$2.63K	0.01%	216
2026 Q1	$59.4K	Buy	426 +134	+46%	+$18.8K	0.02%	158
2025 Q4	$35.8K	Sell	292 -3,289	-92%	-$400K	0.01%	167
2025 Q3	$397K	Hold	3,581	–	–	0.11%	77
2025 Q2	$397K	Buy	3,581 +19	+0.5%	+$2.02K	0.12%	76
2025 Q1	$399K	Buy	3,562 +21	+0.6%	+$2.17K	0.13%	75
2024 Q4	$327K	Buy	3,541 +73	+2%	+$6.57K	0.11%	82
2024 Q3	$291K	Buy	3,468 +11	+0.3%	+$839	0.1%	88
2024 Q2	$237K	Buy	3,457 +7	+0.2%	+$467	0.09%	93
2024 Q1	$253K	Hold	3,450	–	–	0.1%	90
2023 Q4	$279K	Hold	3,450	–	–	0.14%	88
2023 Q3	$259K	Buy	3,450 +100	+3%	+$7.69K	0.16%	80
2023 Q2	$258K	Hold	3,350	–	–	0.16%	81
2023 Q1	$278K	Hold	3,350	–	–	0.19%	80
2022 Q4	$288K	Hold	3,350	–	–	0.21%	83
2022 Q3	$207K	Buy	+3,350	New	+$211K	0.17%	79

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Highline Wealth Partners's GILD Position: Q2 2026 in Review

Highline Wealth Partners increased its Gilead Sciences (GILD) stake by 4.7% in Q2 2026, buying an estimated $2.63K and bringing the position to 446 shares worth $56.3K. The position accounts for 0.01% of the portfolio, ranked #216.

Highline Wealth Partners first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $399K in Q1 2025. 425 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Highline Wealth Partners held 446 shares of Gilead Sciences worth $56.3K as of Q2 2026.
Highline Wealth Partners bought 20 Gilead Sciences shares in Q2 2026, an estimated $2.63K.
Gilead Sciences made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #216 holding.
Highline Wealth Partners first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
Highline Wealth Partners's Gilead Sciences position peaked at $399K in Q1 2025.
425 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.